TCOT
DMRA

Trust Company of Toledo’s Damora Therapeutics DMRA Stock Holding History

Trust Company of Toledo’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-897
Closed -$56.5K – 215
2023
Q2 		$56.5K Buy
897
+417
+87% +$22.7K 0.01% 199
2023
Q1 		$23.9K Buy
+480
New +$25.3K ﹤0.01% 203

Other funds holding DMRA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trust Company of Toledo's DMRA Position: Q3 2023 in Review

Trust Company of Toledo sold out of Damora Therapeutics (DMRA) in Q3 2023, closing a stake of 897 shares — an estimated $56.5K sold.

Trust Company of Toledo first reported a position in DMRA in Q1 2023 and held it in 2 quarters. The position peaked at $56.5K in Q2 2023. 21 funds tracked by Wall St. Rank hold DMRA as of Q3 2023.

  • Trust Company of Toledo reported no remaining Damora Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Trust Company of Toledo sold 897 Damora Therapeutics shares in Q3 2023, an estimated $56.5K.
  • Trust Company of Toledo first reported a position in Damora Therapeutics in Q1 2023 and held it in 2 quarters.
  • Trust Company of Toledo's Damora Therapeutics position peaked at $56.5K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2023.

Based on Trust Company of Toledo's 13F filing for Q3 2023, filed 19 Oct 2023.